NCT02753127 2023-11-15CanStem303CSumitomo Pharma America, Inc.Phase 3 Completed1,253 enrolled 18 charts
NCT02759588 2023-01-05GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian CancerGenelux CorporationPhase 1/2 Completed46 enrolled